Multicenter, randomized, parallel-group, double-blind, placebo-controlled phase III stud of the efficacy and safety of quetiapine fumarate and lithium as monotherapy in 28 to 104 weeks maintenance treatment of bipolar I disorder in adult patient

Trial Profile

Multicenter, randomized, parallel-group, double-blind, placebo-controlled phase III stud of the efficacy and safety of quetiapine fumarate and lithium as monotherapy in 28 to 104 weeks maintenance treatment of bipolar I disorder in adult patient

Recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Mar 2006

At a glance

  • Drugs Lithium; Quetiapine
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top